Prof. Dr Fuling Zhou, Department of Hematology Zhongnan Hospital of Wuhan University, China
Prof. Dr. Fuling Zhou is a globally recognized medical scientist and tenured Full Professor of Hematology at Zhongnan Hospital, Wuhan University. As Director of the Department of Hematology, she has led pioneering research into blood diagnostics and targeted molecular therapies for hematologic malignancies. With an impressive publication record and a global training background from top U.S. institutions, including MD Anderson Cancer Center and Stanford Research Institute, Dr. Zhou has made significant contributions to translational and clinical hematology. She is included in the Stanford University’s prestigious list of the World’s Top 2% Scientists and has received accolades such as the “New Century High-Level Talents” award from Hubei Province. Her research has not only advanced the understanding of blood cancers but has also contributed 26 national patents, reflecting her drive toward innovation and impact in patient care. Her leadership and mentorship roles further underscore her influence in the scientific and medical community.
Publication Profile
Scopus
Education
Dr. Zhou completed her M.D. and Ph.D. in Medicine from Xi’an Jiaotong University, one of China’s most prestigious institutions. Following her doctoral studies, she pursued two prestigious postdoctoral fellowships in the United States. From 2011 to 2013, she worked at the Department of System Biology at The University of Texas MD Anderson Cancer Center, where she was engaged in cutting-edge cancer biology research. She furthered her training at the Department of Biomedical Sciences, Stanford Research Institute International (2013–2014), focusing on the intersection of molecular biology and translational applications. Her international academic background provided her with a global perspective and technical depth, enabling her to pioneer sophisticated diagnostic approaches and molecular therapies in hematology. Her training at these globally recognized institutions has equipped her to lead innovative research programs and train the next generation of clinical scientists.
Experience
Prof. Dr. Fuling Zhou currently serves as the Director of the Department of Hematology at Zhongnan Hospital, Wuhan University, and holds a tenured Full Professorship. In addition to her academic and clinical leadership, she actively serves in various national and regional professional associations. She is a member of the Hematology Branch of the Chinese Medical Doctor Association and of the Educational Technology Branch of the Chinese Medical Association. She chairs the Hematologic Malignancies Committee of the Hubei Clinical Oncology Society and the Youth Committee of the Hubei Medical Immunology Society. Furthermore, she serves as the Vice Chairman of the Hubei Women’s Federation of Health. These leadership positions reflect her influence in guiding policy, promoting education, and advancing research in hematologic diseases. Her work bridges laboratory innovation and clinical application, making her a central figure in China’s hematology community and beyond.
Honors & Awards
Dr. Fuling Zhou has received multiple prestigious accolades in recognition of her exceptional contributions to medical science. Most notably, she was listed among Stanford University’s World’s Top 2% Scientists, an honor recognizing outstanding global scientific impact and citation excellence. She has also been recognized as one of the New Century High-Level Talents of Hubei Province, underlining her regional leadership and innovation in healthcare. In addition to institutional awards, Dr. Zhou has secured 26 national patents for her breakthroughs in diagnostics and treatment of blood cancers, showcasing her commitment to transforming research into practical solutions. Her success in securing competitive grants and her role in shaping national research agendas have elevated her as a thought leader in hematology. These awards validate not just her scientific acumen but her visionary leadership in translating biomedical research into life-saving therapies.
Research Focus
Prof. Zhou’s research centers on blood detection technologies and molecular targeted therapies for hematologic malignancies such as leukemia, lymphoma, and multiple myeloma. She integrates cutting-edge imaging cytometry, molecular diagnostics, and gene expression profiling to identify novel therapeutic targets and resistance pathways. Her work on high-throughput flow cytometry, JAK/STAT signaling, and hypoxia-induced drug resistance has added new dimensions to understanding leukemia biology. A particular focus has been placed on chemoresistance mechanisms, stem cell modeling, and immune responses in hematologic cancer progression. Her translational research bridges the gap between bench science and clinical treatment, leading to improvements in diagnostics, prognostics, and personalized therapy. With over 30 peer-reviewed publications and collaborations across institutions, Dr. Zhou is driving a new era of precision medicine in hematology, ensuring that her research has a meaningful impact on patient survival and quality of life.
Publication Top Notes
Imaging flow cytometry with a real-time throughput beyond 1,000,000 events per second